Denna sida har översatts automatiskt och översättningens korrekthet kan inte garanteras. Vänligen se engelsk version för en källtext.

Patient-Reported Outcomes of Four Intraoral Suture Materials

28 april 2026 uppdaterad av: Omar Amjad Karadsheh, University of Jordan

Patient-Reported Outcomes Following Application of Intraoral Sutures: A Split-Mouth Randomized Controlled Trial

When patients undergo minor oral surgery, dentists use various types of stitches (sutures) to help the gums heal. These stitches can be made of different materials, and some might feel more comfortable, cause less pain, or interfere less with eating and speaking than others.

The purpose of this study is to compare four commonly used dental suture materials to see which ones patients prefer. Participants in this study will receive four different types of stitches in different areas of their upper jaw after a routine dental procedure.

Patients will be asked to report their levels of pain, discomfort, and any difficulties with daily activities like eating and talking on Days 3, 7, and 14 after the procedure. A panel of dental specialists will also examine photos of the healing process to see if one material helps the mouth heal better than others. This research will help dentists choose the best materials to improve patient comfort after oral surgery.

Studieöversikt

Detaljerad beskrivning

Study Design:

This is a split-mouth, randomized controlled clinical trial designed to evaluate patient-reported outcome measures (PROMs) and clinical healing associated with four different intraoral suture materials.

Methodology:

A total of 60 participants requiring multiple sutures in the maxillary arch will be recruited. Following the surgical procedure under local anesthesia, four types of sutures (e.g., Silk, Polyglactin 910, Polyamide, and Poliglecaprone 25) will be placed in a randomized sequence across four standardized sites in a single hemi-arch:

Site A: Anterior Buccal

Site B: Posterior Buccal

Site C: Anterior Palatal

Site D: Posterior Palatal

Randomization and Blinding:

Suture materials will be assigned to sites using a computer-generated randomization table. The study is single-blinded; patients will not be informed which material is placed at which site. A blinded panel of three periodontists will evaluate clinical healing via standardized digital photographs.

Data Collection:

Patient-Reported Outcomes: Participants will complete a Visual Analog Scale (VAS) and Likert-type scales to assess pain, awareness of the suture, tissue irritation, and functional interference (speaking and eating) on post-operative Days 3, 7, and 14.

Suture Removal: Pain during suture removal will be recorded at Day 7.

Clinical Healing: Healing will be assessed by the expert panel using the Landry, Turnbull, and Howley Index (1988) based on photographs taken at Day 7 and Day 14.

Primary Objective:

To identify which suture material provides the highest level of patient comfort and the least functional interference during the first two weeks of healing.

Secondary Objective:

To compare the clinical tissue response and healing scores between braided and monofilament suture materials in the oral cavity.

Studietyp

Interventionell

Inskrivning (Beräknad)

60

Fas

  • Inte tillämpbar

Deltagandekriterier

Forskare letar efter personer som passar en viss beskrivning, så kallade behörighetskriterier. Några exempel på dessa kriterier är en persons allmänna hälsotillstånd eller tidigare behandlingar.

Urvalskriterier

Åldrar som är berättigade till studier

  • Vuxen

Tar emot friska volontärer

Ja

Beskrivning

Inclusion Criteria:

Adults aged 20-30 years.

Systemically healthy (ASA I-II).

No history of allergy to study suture materials.

Periodontally healthy, with no active oral lesions, including carious lesions.

Dental Requirements: All maxillary canine, second premolar, and first molar teeth present.

Minimal (≤0.5 mm) open contacts between the pairs of teeth that define the study sites.

Ideally, full maxillary dentition present from first molar to first molar.

At least 2 mm of keratinized tissue width on buccal intervention sites.

Willing and able to provide informed consent.

Willing and able to attend all study follow-up visits and complete study questionnaires.

Exclusion Criteria:

Allergy to any study materials (e.g., suture materials or anesthetics) or medications (Paracetamol).

Any systemic disease affecting wound healing (e.g., diabetes, immunosuppression).

Use of any medications.

Pregnancy or lactation.

Unwillingness or inability to provide informed consent.

Unwillingness or inability to comply with study protocol and follow-up visits.

Exit Criteria:

Participants may exit the study at any time if they wish to discontinue participation.

Noncompliance with study protocol and visits.

Development of conditions (e.g., infection) that require immediate care or that introduce exclusion criteria.

Studieplan

Det här avsnittet ger detaljer om studieplanen, inklusive hur studien är utformad och vad studien mäter.

Hur är studien utformad?

Designdetaljer

  • Primärt syfte: Stödjande vård
  • Tilldelning: N/A
  • Interventionsmodell: Enskild gruppuppgift
  • Maskning: Ingen (Open Label)

Vapen och interventioner

Deltagargrupp / Arm
Intervention / Behandling
Experimentell: Suture Comparison Group
A single group of 60 participants. Each participant serves as their own control (split-mouth design). Every participant will receive four different suture materials placed in four distinct sites (Anterior Buccal, Posterior Buccal, Anterior Palatal, Posterior Palatal) in the maxillary arch.
4-0 Black Braided Silk suture. Used for soft tissue approximation.
4-0 Synthetic braided absorbable suture (e.g., Vicryl).
4-0 Nylon monofilament suture.
4-0 Synthetic monofilament absorbable suture (e.g., Monocryl).

Vad mäter studien?

Primära resultatmått

Resultatmått
Åtgärdsbeskrivning
Tidsram
Patient-Reported Pain and Discomfort (VAS)
Tidsram: Post-operative Day 3
Subjective assessment of pain and discomfort for each of the four suture sites using a Visual Analog Scale (VAS) ranging from 0 (no pain/discomfort) to 100 (worst possible pain/discomfort).
Post-operative Day 3

Sekundära resultatmått

Resultatmått
Åtgärdsbeskrivning
Tidsram
Clinical Healing Index Score
Tidsram: Post-operative Day 7 and Day 14
Evaluation of soft tissue healing at each suture site using the Landry, Turnbull, and Howley Index (scores 1-5). Assessment will be performed by a blinded panel using standardized clinical photographs.
Post-operative Day 7 and Day 14
Pain Intensity During Suture Removal
Tidsram: Post-operative Day 7
Subjective pain level reported by the participant specifically during the process of removing the sutures at Day 7, measured on a 0-100 VAS.
Post-operative Day 7
Impact on Daily Activities (Speech and Eating)
Tidsram: Post-operative Day 3 and Day 7
Patient-reported difficulty in speaking and eating caused by the sutures, measured on a Likert-type scale (0-10).
Post-operative Day 3 and Day 7

Samarbetspartners och utredare

Det är här du hittar personer och organisationer som är involverade i denna studie.

Publikationer och användbara länkar

Den som ansvarar för att lägga in information om studien tillhandahåller frivilligt dessa publikationer. Dessa kan handla om allt som har med studien att göra.

Studieavstämningsdatum

Dessa datum spårar framstegen för inlämningar av studieposter och sammanfattande resultat till ClinicalTrials.gov. Studieposter och rapporterade resultat granskas av National Library of Medicine (NLM) för att säkerställa att de uppfyller specifika kvalitetskontrollstandarder innan de publiceras på den offentliga webbplatsen.

Studera stora datum

Studiestart (Beräknad)

1 juli 2026

Primärt slutförande (Beräknad)

1 mars 2027

Avslutad studie (Beräknad)

1 april 2028

Studieregistreringsdatum

Först inskickad

14 april 2026

Först inskickad som uppfyllde QC-kriterierna

28 april 2026

Första postat (Faktisk)

6 maj 2026

Uppdateringar av studier

Senaste uppdatering publicerad (Faktisk)

6 maj 2026

Senaste inskickade uppdateringen som uppfyllde QC-kriterierna

28 april 2026

Senast verifierad

1 april 2026

Mer information

Termer relaterade till denna studie

Andra studie-ID-nummer

  • 2046
  • 158/2025-2026 (Annat bidrag/finansieringsnummer: The University of Jordan)

Plan för individuella deltagardata (IPD)

Planerar du att dela individuella deltagardata (IPD)?

NEJ

Läkemedels- och apparatinformation, studiedokument

Studerar en amerikansk FDA-reglerad läkemedelsprodukt

Nej

Studerar en amerikansk FDA-reglerad produktprodukt

Nej

Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .

Prenumerera